10th Nov 2026 07:00
Condensed Consolidated Interim Statement of Financial Position as at September 30, 2026 Click on, or paste the following link into your web browser, to view the full announcement text:http://www.rns-pdf.londonstockexchange.com/rns/4302C_1-2026-11-9.pdf | |||||
|
| Notes | Sep. 30, 2026 |
| Dec. 31, 2025 |
| Assets |
|
|
|
|
| Cash and balances at the central bank | 14 | 100,683,255 |
| 88,876,452 |
| Due from banks | 15 | 276,032,791 |
| 135,236,549 |
| Loans and advances to banks, net | 17 | 51,133,049 |
| 34,440,770 |
| Loans and advances to customers, net | 18 | 621,932,771 |
| 507,953,766 |
| Derivative financial instruments |
| 36,516 |
| 620,349 |
| Financial investments |
|
|
|
|
| - Financial Assets at Fair Value through OCI | 19.1 | 380,837,034 |
| 376,397,929 |
| - Financial Assets at Amortized cost | 19.1 | 329,696,032 |
| 236,672,175 |
| Investments in associates | 20 | 40,046 |
| 45,210 |
| Non-current assets held for sale | 32 | 186,801 |
| 182,827 |
| Other assets | 21 | 57,807,316 |
| 54,040,912 |
| Deferred tax assets |
| 1,292,214 |
| 2,545,499 |
| Property and equipment | 22 | 6,499,307 |
| 5,481,682 |
| Total assets |
| 1,826,177,132 |
| 1,442,494,120 |
| Liabilities and equity |
|
|
|
|
| Liabilities |
|
|
|
|
| Due to banks | 23 | 23,410,893 |
| 3,353,746 |
| Due to customers | 24 | 1,448,932,282 |
| 1,110,395,693 |
| Non-current liabilities held for sale | 33 | 3,971 |
| 53,860 |
| Derivative financial instruments |
| 282,234 |
| 137,802 |
| Current income tax liabilities |
| 16,107,190 |
| 20,570,313 |
| Other liabilities | 25 | 31,070,992 |
| 25,595,390 |
| Issued debt instruments | 26 | - |
| 4,761,558 |
| Other loans |
| 32,300,727 |
| 30,471,499 |
| Other provisions | 27 | 15,620,459 |
| 15,640,041 |
| Total liabilities |
| 1,567,728,748 |
| 1,210,979,902 |
| Equity |
|
|
|
|
| Issued and paid capital |
| 34,051,391 |
| 33,779,361 |
| Reserves |
| 132,903,315 |
| 105,849,176 |
| Reserve for employee stock ownership plan (ESOP) |
| 2,718,833 |
| 2,343,532 |
| Retained earnings* |
| 88,734,176 |
| 89,514,273 |
| Total equity and net profit for the period / year |
| 258,407,715 |
| 231,486,342 |
| Non-Controlling Interest |
| 40,669 |
| 27,876 |
| Total NCI, equity and net profit for the period / year |
| 258,448,384 |
| 231,514,218 |
| Total liabilities and equity |
| 1,826,177,132 |
| 1,442,494,120 |
|
|
|
|
|
|
| The accompanying notes are an integral part of these financial statements. |
|
|
|
|
| (Review report attached) |
|
|
|
|
* | Including net profit for the period |
|
|
|
|
Condensed Consolidated Interim Income Statement for The Period Ended September 30, 2026 | |||
|
| Last 9 Months | Last 9 Months |
| Notes | Sep. 30, 2026 | Sep. 30, 2025 |
Interest and similar income |
| 175,127,298 | 158,400,209 |
Interest and similar expense |
| (81,871,918) | (79,746,672) |
Net interest income |
| 93,255,380 | 78,653,537 |
|
|
|
|
Fee and commission income |
| 15,602,836 | 11,609,232 |
Fee and commission expense |
| (6,480,082) | (5,227,210) |
Net fee and commission income |
| 9,122,754 | 6,382,022 |
|
|
|
|
Dividend income |
| 186,512 | 65,216 |
Net trading income | 9 | 2,777,904 | 1,282,250 |
Profits (losses) on financial investments | 19.2 | 360,970 | 694,076 |
Administrative expenses |
| (15,973,729) | (12,432,780) |
Other operating income (expenses) | 10 | (3,810,428) | 668,432 |
Release (charges) for ECL | 11 | 1,136,732 | 7,968,084 |
Bank's share in the profits (losses) of associates |
| 7,127 | 9,787 |
Profit before income tax |
| 87,063,222 | 83,290,624 |
|
|
|
|
Income tax expense | 12 | (23,091,927) | (21,842,182) |
Deferred tax assets (liabilities) | 12 | (891,939) | 651,822 |
Net profit for the period |
| 63,079,356 | 62,100,264 |
|
|
|
|
Non-Controlling Interest |
| 2,296 | 569 |
Bank's shareholders |
| 63,077,060 | 62,099,695 |
|
|
|
|
Earnings per share | 13 |
|
|
Basic |
| 16.66 | 16.84 |
Diluted |
| 16.45 | 16.64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Islam Zekry | Hisham Ezz Al-Arab | ||
Group CFO & Executive Board Member | CEO & Executive Board Member | ||
|
|
|
|
| Condensed Consolidated Interim Statement of Comprehensive Income for The Period Ended September 30, 2026 | ||
|
| Last 9 Months | Last 9 Months |
|
| Sep. 30, 2026 | Sep. 30, 2025 |
| Net profit for the period | 63,079,356 | 62,100,264 |
| Transferred to RE from financial assets at fair value through OCI | (50,973) | (110,995) |
| Net change on financial assets at fair value through comprehensive income after tax | (7,818,733) | 7,306,189 |
| Cumulative foreign currencies translation differences | 424,371 | (274,766) |
| Effect of ECL on debt instruments measured at fair value through OCI | (1,213,889) | (397,890) |
| Total comprehensive income for the period | 54,420,132 | 68,622,802 |
|
|
|
|
| As follows: |
|
|
| Bank's shareholders | 54,392,324 | 68,508,336 |
| Non-Controlling Interest | 27,808 | 114,466 |
| Total comprehensive income for the period | 54,420,132 | 68,622,802 |
Condensed Consolidated Interim Cash Flows for The Period Ended September 30, 2026 | ||||
|
| Notes | Sep. 30, 2026 | Sep. 30, 2025 |
| Cash flow from operating activities |
|
|
|
| Profit before income tax |
| 87,063,222 | 83,290,624 |
| Adjustments to reconcile profits to net cash provided by operating activities |
|
|
|
| Fixed assets depreciation | 22 | 1,828,564 | 1,680,325 |
| Impairment release/charge for credit losses (loans and advances to customers and banks) | 11 | (498,717) | (7,969,627) |
| Net charge/release for other provisions | 27 | 705,385 | (4,072,083) |
| Impairment release/charge for credit losses (due from banks) | 11 | 10,906 | 147,709 |
| Impairment release/charge for credit losses (financial investments) | 11 | (648,921) | (146,166) |
| Impairment release/charge for other assets |
| - | 105 |
| Exchange revaluation differences for financial assets at fair value through OCI and AC |
| (15,027,946) | 4,669,694 |
| Revaluation differences impairment charge for Financial Assets at Fair value through OCI |
| 348,094 | (224,869) |
| Revaluation differences impairment charge for Financial Assets at Amortized cost |
| 37,339 | (16,709) |
| Revaluation differences impairment charge for due from banks |
| 12,061 | (7,894) |
| Net utilized/recovered for other provisions | 27 | (1,205,250) | (2,039) |
| Exchange revaluation differences of other provisions | 27 | 480,283 | (52,461) |
| Profits/losses from selling property and equipment |
| (4,420) | (8,006) |
| Profits/losses from selling financial investments at fair value through OCI | 19.2 | (360,970) | (416,668) |
| Profits/losses from selling investments in associates | 19.2 | - | (277,408) |
| Share based payments |
| 1,218,347 | 990,324 |
| Bank's share in the profits/losses of associates |
| (7,127) | (9,787) |
| Operating profits before changes in operating assets and liabilities |
| 73,950,850 | 77,575,064 |
|
|
|
|
|
| Net decrease / increase in assets and liabilities |
|
|
|
| Due from banks |
| (23,476,003) | 159,740,470 |
| Financial assets at fair value through P&L |
| - | (2,203,869) |
| Derivative financial instruments |
| 370,892 | (306,569) |
| Loans and advances to banks and customers |
| (130,170,746) | (121,599,501) |
| Other assets |
| (415,249) | (2,747,423) |
| Non-current assets held for sale | 32 | (3,974) | - |
| Due to banks | 23 | 20,057,147 | 5,417,359 |
| Due to customers | 24 | 338,536,589 | 74,868,032 |
| Current income tax obligations paid |
| (6,984,737) | (5,984,364) |
| Non-current liabilities held for sale | 33 | (49,889) | (35) |
| Other liabilities |
| (14,632,537) | (12,910,605) |
| Net cash generated from (used in) operating activities |
| 257,182,343 | 171,848,559 |
|
|
|
|
|
| Cash flow from investing activities |
|
|
|
| Proceeds from sale of investments in associates |
| - | 339,920 |
| Payments for purchases of property, equipment and branches construction |
| (6,199,165) | (6,216,697) |
| Proceeds from selling property and equipment | 10 | 4,420 | 8,006 |
| Proceeds from redemption of financial assets at amortized cost |
| 13,737,391 | 21,382,288 |
| Payments for purchases of financial assets at amortized cost |
| (106,087,764) | (84,177,641) |
| Payments for purchases of financial assets at fair value through OCI |
| (156,447,793) | (191,735,116) |
| Proceeds from selling financial assets at fair value through OCI |
| 158,659,118 | 98,091,318 |
| Net cash generated from (used in) investing activities |
| (96,333,793) | (162,307,922) |
| ||||
Condensed Consolidated Interim Cash Flows for The Period Ended September 30, 2026 (Cont.) | ||||
|
|
| Sep. 30, 2026 | Sep. 30, 2025 |
|
|
|
|
|
| Cash flow from financing activities |
|
|
|
| Other loans |
| 1,829,228 | 6,286,889 |
| Dividends |
| (29,052,828) | (14,773,854) |
| Issued debt instruments |
| (4,761,558) | (288,320) |
| Capital increase |
| 272,030 | 276,930 |
| Net cash generated from (used in) financing activities |
| (31,713,128) | (8,498,355) |
|
|
|
|
|
| Net increase (decrease) in cash and cash equivalent during the period |
| 129,135,422 | 1,042,282 |
| Beginning balance of cash and cash equivalent |
| 140,542,556 | 226,610,721 |
| Cash and cash equivalent at the end of the period |
| 269,677,978 | 227,653,003 |
|
|
|
|
|
| Cash and cash equivalent comprise: |
|
|
|
| Cash and balances at the central bank | 14 | 100,683,255 | 21,886,031 |
| Due from banks |
| 276,188,440 | 227,553,557 |
| Treasury bills and other governmental notes | 16 | 187,629,210 | 141,529,607 |
| Obligatory reserve balance with central bank |
| (73,788,712) | (2,865,828) |
| Due from banks with maturity more than three months |
| (33,405,005) | (19,202,757) |
| Treasury bills and other governmental notes with maturity more than three months |
| (187,629,210) | (141,247,607) |
| Total cash and cash equivalent |
| 269,677,978 | 227,653,003 |
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity |
|
|
|
|
|
|
| ||||||||||||||||
Sep. 30, 2025 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders’ Equity | Non-Controlling Interest | Total | ||||||||
Beginning balance | 30,431,580 | 6,208,674 | 62,422,792 | 1,550,906 | - | (670,972) | 22,818 | (7,145,283) | 17,924 | 56,791,883 | 1,868,235 | 1,137,720 | 152,636,277 | 183,044 | 152,819,321 | ||||||||
Capital increase | 276,930 | - | - | - | - | - | - | - | - | - | - | - | 276,930 | - | 276,930 | ||||||||
Transferred to reserves | - | 2,771,284 | 19,758,610 | - | - | - | 2,246 | - | - | (21,744,828) | (787,312) | - | - | - | - | ||||||||
Net profit for the period | - | - | - | - | - | - | - | - | - | 62,099,695 | - | - | 62,099,695 | 569 | 62,100,264 | ||||||||
Dividends paid | - | - | - | - | - | - | - | - | - | (14,714,434) | - | - | (14,714,434) | (59,420) | (14,773,854) | ||||||||
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (110,995) | - | 110,995 | - | - | - | - | - | ||||||||
Transferred to general risk reserve | - | - | - | 26,186 | - | - | - | - | - | (26,186) | - | - | - | - | - | ||||||||
Transferred from net profit to special reserve | - | - | - | - | 13,145,012 | - | - | - | - | (13,145,012) | - | - | - | - | - | ||||||||
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | 7,192,292 | - | - | - | - | 7,192,292 | 113,897 | 7,306,189 | ||||||||
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | (2,628) | 2,628 | - | - | - | - | - | ||||||||
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | (397,890) | - | - | - | - | (397,890) | - | (397,890) | ||||||||
Cost of employees' stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 990,324 | - | 990,324 | - | 990,324 | ||||||||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | (274,766) | (274,766) | - | (274,766) | ||||||||
Ending balance | 30,708,510 | 8,979,958 | 82,181,402 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | (461,876) | 15,296 | 69,374,741 | 2,071,247 | 862,954 | 207,808,428 | 238,090 | 208,046,518 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Sep. 30, 2026 | Issued and paid capital | Legal reserve | General reserve | General risk reserve | Special reserve | Reserve for transactions under common control | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders’ Equity | Non-Controlling Interest | Total | ||||||||
Beginning balance | 33,779,361 | 8,979,958 | 79,110,551 | 1,577,092 | 13,145,012 | (670,972) | 25,064 | 2,825,146 | 15,296 | 89,514,273 | 2,343,532 | 842,029 | 231,486,342 | 27,876 | 231,514,218 | ||||||||
Capital increase | 272,030 | - | - | - | - | - | - | - | - | - | - | - | 272,030 | - | 272,030 | ||||||||
Transferred to reserves | - | 4,089,832 | 31,449,216 | - | - | - | 13,005 | - | - | (34,709,007) | (843,046) | - | - | - | - | ||||||||
Dividends paid | - | - | - | - | - | - | - | - | - | (29,037,813) | - | - | (29,037,813) | (15,015) | (29,052,828) | ||||||||
Net profit for the period | - | - | - | - | - | - | - | - | - | 63,077,060 | - | - | 63,077,060 | 2,296 | 63,079,356 | ||||||||
Transferred to RE from financial assets at fair value through OCI | - | - | - | - | - | - | - | (25,461) | - | 25,461 | - | - | - | 25,512 | 25,512 | ||||||||
Transferred to general risk reserve | - | - | - | 144,602 | - | - | - | - | - | (144,602) | - | - | - | - | - | ||||||||
Net change on financial assets at fair value through OCI after tax | - | - | - | - | - | - | - | (7,818,733) | - | - | - | - | (7,818,733) | - | (7,818,733) | ||||||||
Transferred (from) to banking risk reserve | - | - | - | - | - | - | - | - | (8,804) | 8,804 | - | - | - | - | - | ||||||||
Effect of ECL on debt instruments measured at fair value through OCI | - | - | - | - | - | - | - | (1,213,889) | - | - | - | - | (1,213,889) | - | (1,213,889) | ||||||||
Cost of employees' stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | - | - | 1,218,347 | - | 1,218,347 | - | 1,218,347 | ||||||||
Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | - | - | 424,371 | 424,371 | - | 424,371 | ||||||||
Ending balance | 34,051,391 | 13,069,790 | 110,559,767 | 1,721,694 | 13,145,012 | (670,972) | 38,069 | (6,232,937) | 6,492 | 88,734,176 | 2,718,833 | 1,266,400 | 258,407,715 | 40,669 | 258,448,384 | ||||||||
Related Shares:
Com.int.bk.regs